4th International Conference on Biochemistry & Metabolomics
Los Angeles, USA
Hamid Mirzaei
UT Southwestern Medical Center, USA
Biography
Dr. Mirzaei’s research is focused on finding the target of novel and FDA approved compounds using a combination of proteomics, computational biology and biochemistry. Many FDA approved drugs are currently in use without clear understanding of their mechanism of action. On the other hand there are quite a few well-characterized natural products with unknown targets. Dr. Mirzaei uses systems biology to understand the drug’s mechanism of action by identifying the target of the drugs and their cellular and organismal phenotypes.